Despite indications that a single dose of Merck's (NYSE:MRK) human papillomavirus vaccine Gardasil could be as effective as the current multi-dosing schedule, the drugmaker said that an ...

Merck – known as MSD outside the US and Canada – hasn't broken down the payments but said they include an upfront payment plus development, regulatory and commercialization milestones.

Cancer Surveillance in the United States in Jeopardy: Leveraging 21st Century Technology to Enhance Public Health Patients age 20 years and older with AGC, who had experienced disease progression ...

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical ...

Competition from the bispecifics could be a big deal for MSD – known as Merck & Co in the US and Canada – given that Keytruda contributed $25 billion of its $60.1 billion global sales last year.

TME Pharma N.V. (Euronext Growth Paris: ALTME),a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME ...

Lifehacker has been a go-to source of tech help and life advice since 2005. Our mission is to offer reliable tech help and credible, practical, science-based life advice to help you live better ...

BERLIN--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by ...

The global Breast Biopsy Devices Market, valued at US$2,255.0 million in 2024, is forecasted to grow at a robust CAGR of 6.5%, reaching US$2,384.1 million in 2025 and an impressive US$3,261.7 million ...

More Bonds of MSD Netherlands Capital B.V. Moody’s Daily Credit Risk Score About the MSD Netherlands Capital B.V.-Bond (XS2825485183) The MSD Netherlands Capital B.V.-Bond has a maturity date of ...